首页> 外文期刊>European urology >Rebuttal from Authors re: Carlo Terrone, Alessandro Volpe. The Role of Pathology for Clinical Decision-Making in Renal Cell Carcinoma is Increasing. Eur Urol 2007;51:1166-8.
【24h】

Rebuttal from Authors re: Carlo Terrone, Alessandro Volpe. The Role of Pathology for Clinical Decision-Making in Renal Cell Carcinoma is Increasing. Eur Urol 2007;51:1166-8.

机译:作者的反驳:卡洛·特罗纳(Carlo Terrone),亚历山德罗·沃尔佩(Alessandro Volpe)。病理学在肾细胞癌临床决策中的作用正在增加。 Eur Urol 2007; 51:1166-8。

获取原文
获取原文并翻译 | 示例
           

摘要

The oncologic urologist relies on an informative, detailed, and exact pathologic result for the optimal management of the patient with urologic cancel. The pathology report should not only contain the correct histopathologic diagnosis but also mention other parameters that are known to be of prognostic importance. It is also a crucial task for this team to identify new parameters that may aid and guide the oncologic urologist to perform better treatment and follow-up. The understanding, cooperation, and coordination between the urologist and pathologist are essential for the mutual benefit of the patient.
机译:肿瘤泌尿科医师依靠信息丰富,详细而准确的病理结果来对泌尿外科疾病取消的患者进行最佳管理。病理报告不仅应包含正确的组织病理学诊断,还应提及已知对预后具有重要意义的其他参数。对于这个团队来说,确定新的参数也是一项至关重要的任务,这些参数可以帮助并指导肿瘤泌尿科医师进行更好的治疗和随访。泌尿科医师和病理学家之间的理解,合作与协调对于患者的共同利益至关重要。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号